Chad M. Cohen, Chief Financial Officer at Adaptive Biotechnologies Corp (ADPT), sold 20,000 shares at $40.79 ($805K) on 2021-03-09, disclosed to the SEC on 2021-03-10.
Open-market sale of $805k ADPT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.02 | 7,110 | $285K | 35.4% |
| 2 | $40.02 | 7,110 | $285K | 35.4% |
| 3 | $40.79 | 2,890 | $118K | 14.6% |
| 4 | $40.79 | 2,890 | $118K | 14.6% |
| Total | $40.24 avg | 20,000 | $805K | 100% |
| Filing → |
| ADPT | SELL | 2021-10-07 | $324K | — | Filing → |
| ADPT | SELL | 2021-09-09 | $940K | — | Filing → |
| ADPT | SELL | 2021-08-12 | $804K | — | Filing → |